Ariella,
Thanks for the analysis. Wish I had some free cash to load on more shares, but am happy with my current position and its average price.
Meanwhile, from today's Globes, some harsh words regarding PARS PR:
"A share like Pharmos, for example, will not
emerge from the grave it is in at present unless
it urgently sends Wall Street a series of clear
and attractive messages. It isn't enough to set
up an Internet site and say that's it, we've done
it. It's also necessary to hire the services of
professional people such as Deb Triant (Check
Point), who know how to say all the right things
in all the right places. It costs money, but
perhaps the time has come to cut spending on a
lab rat. Or maybe two."
While I question the choice of words, in essence the author is exactly right. Hope Pharmos management is taking notes.
Here's the link: globes.co.il
Best regards,
Zvi |
